Insulet Corporation’s cover photo
Insulet Corporation

Insulet Corporation

Medical Equipment Manufacturing

Acton, Massachusetts 140,438 followers

About us

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe. HIRING SCAM ALERT Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that: • Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message. • Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment. • Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment. If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000. If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.

Website
http://www.insulet.com/
Industry
Medical Equipment Manufacturing
Company size
1,001-5,000 employees
Headquarters
Acton, Massachusetts
Type
Public Company
Specialties
Medical Devices, Diabetic Management, Biotechnology, Medical Supply, Advanced Manufacturing, and Medical Supply Chain

Locations

Employees at Insulet Corporation

Updates

  • We are proud to share that Insulet has been recognized by Newsweek with two 2026 workplace honors: America’s Greatest Workplaces for Trust and America’s Greatest Workplaces for Perks & Benefits. These recognitions reflect the culture our teams help create every day, one built on trust, collaboration, support, and a shared commitment to our mission. At Insulet, we are committed to fostering an environment where employees feel empowered to grow, contribute, and make a meaningful impact. Thank you to our team members around the world who make our workplace and culture so special. #TeamInsulet

  • Great conversations start with curiosity. That was on full display recently when Insulet’s Senior Vice President and Chief Technology Officer, Amit Guliani, convened our teams for a discussion on the future of technology at Insulet. Team Insulet members from around the world brought their curiosity and candor to the conversation, asking direct and thoughtful questions about the innovations ahead, and what it truly takes to rethink how we deliver better experiences for the people we serve. Moments like this are what keep Insulet’s culture strong: transparent leadership, bold ideas, and a shared commitment to improving the lives of people with diabetes. #TeamInsulet

    • No alternative text description for this image
  • Please join us in welcoming Javerris Hall to Team Insulet! Jay joins us as a Territory Manager serving our Podders in Southern California. In his new role, Jay will be on the front lines of building relationships with healthcare providers and connecting people with diabetes to our Company’s innovative Omnipod technology. Welcome to the team, Jay. We’re glad you’re here! #TeamInsulet

  • Our U.S. Field Sales and Inside Sales teams recently gathered in Orlando, Florida, for back-to-back National Sales Meetings, celebrating outstanding performances and setting the course for the year ahead. Highlights included a special appearance from Podder® Adam Abdin of The Amazing Race and a keynote from President and CEO Ashley McEvoy at the Field Sales meeting. The Inside Sales meeting welcomed Podders Zach White and Elise Scalfani, who met through Omnipod®, and star in the short film My Type, released at the Santa Barbara Film Festival. Regional awards dinners and President's Club Awards capped off a week of connection, recognition, and renewed purpose in support of our Podders. #TeamInsulet

  • Earth Month and Global Volunteer Month are powerful reminders that small actions, taken together, can make a real difference.    Led by our Sustainability ERG, Insulet for Good initiative, and Global Sustainability team, employees around the world showed up throughout April to: • Participate in a Seed Library event  • Support community clean-up efforts  • Host a “Let’s Talk Trash” event to help employees better understand Insulet’s waste infrastructure  Thank you to everyone who gave their time and energy this month. We are proud of the culture of care Team Insulet continues to build for our communities and for our planet.  #TeamInsulet

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Three marketing and PR awards. One incredible team! We are thrilled to share that Dyasonic: Sound of Strength, our collaboration with Marvel, has been recognized with three prestigious industry honors. ⭐ 2026 PRovoke Media Innovation SABRE Award, Branded Content Integration  ⭐ 2026 North American SABRE Award, Inclusive Marketing  ⭐ 2026 PRWeek Healthcare Award, Best in Health Tech This work was born from a simple but powerful belief: that people with diabetes deserve to feel seen, heard, and represented. Seeing that vision come to life and now be recognized across the industry is something our Company is truly proud of. Special thanks to all who played a role in bringing this impactful campaign to life. #TeamInsulet

    • No alternative text description for this image
  • Driving access to Omnipod 5 in international markets remains a key strategic growth priority for Insulet. Since the start of the year, Omnipod® 5 availability has expanded into five countries across the Middle East, helping bring our technology to more people around the world. Senior Vice President and International General Manager Pat Crannell led an engaging session highlighting our global expansion efforts and the opportunities ahead as we continue to grow our international presence. Thank you to all the Team Insulet members who joined the session and contributed to the thoughtful discussion about our Company’s continued growth and impact. #TeamInsulet

    • No alternative text description for this image
  • Join us in congratulating Hjalte Hojsgaard on 15 years with Insulet! Hjalte's journey began on our U.S. consumer marketing team, and over the past 15 years, his career has taken him around the world in the truest sense. He has been a key leader during some of Insulet's most important growth milestones, including the launch of Insulet Canada, Insulet International across the EU, and the first launch of Omnipod 5 outside the United States. Today, Hjalte serves as VP & GM, UK, Netherlands, Belgium, Germany, Austria & Switzerland, where he leads our regional teams across a significant portion of the European market. Thank you, Hjalte, for everything you bring to Insulet and the customers we serve. #TeamInsulet

    • No alternative text description for this image
  • Insulet has been recognized as a finalist for the Outstanding Corporate and Collegiate Partnership Award at the AACC Awards, a national honor open to every community college in the United States! The Pathmaker Program is a collaboration between Insulet, Massachusetts Life Sciences Center, and Middlesex Community College, designed to introduce and educate the next generation of talent in advanced medical device manufacturing. Our Company’s participation is a direct reflection of our commitment to building a strong, skilled, and diverse local workforce. Peter Gowac Jr., Senior Director, U.S. Operations, shared, "Pathmaker is not simply a hiring initiative; it is an investment in people, in education, and in the future of our local workforce. Since the start of the Program, Insulet has hired over 40 graduates, demonstrating both the quality of the training and the alignment between the curriculum and our operational needs." We are grateful to our partners and proud of the meaningful career opportunities this program continues to create. #TeamInsulet

    • No alternative text description for this image
  • Meaningful dialogue on the future of health technology on Capitol Hill. Insulet was pleased to take part in the inaugural Health Tech Innovation Showcase hosted by the Healthcare Trust Institute, Congressman Mike Kelly, and the Bipartisan Health Care Innovation Caucus. It was a valuable opportunity to join fellow innovators, policymakers, and healthcare leaders in conversations about the future of health data access, privacy, trust, and responsible innovation. Events like this matter because advancing healthcare requires more than breakthrough technology — it also requires collaboration, thoughtful policy, and a shared commitment to improving the patient experience. Thanks to Insulet's Head of Federal Government Affairs Albert G. Lytton, Global Head of Government Affairs Katie Hathaway, and the organizers for convening this timely conversation on the future of health technology. #TeamInsulet

Affiliated pages

Similar pages

Browse jobs

Funding

Insulet Corporation 2 total rounds

Last Round

Post IPO debt

US$ 450.0M

See more info on crunchbase